Literature DB >> 35035513

Corrigendum to "Exploring the Pharmacological Mechanism of Liuwei Dihuang Decoction for Diabetic Retinopathy: A Systematic Biological Strategy-Based Research".

Mengxia Yuan1,2, Qi He3, Zhiyong Long2, Xiaofei Zhu2, Wang Xiang2, Yonghe Wu2, Shibin Lin1,2.   

Abstract

[This corrects the article DOI: 10.1155/2021/5544518.].
Copyright © 2022 Mengxia Yuan et al.

Entities:  

Year:  2022        PMID: 35035513      PMCID: PMC8754589          DOI: 10.1155/2022/9790813

Source DB:  PubMed          Journal:  Evid Based Complement Alternat Med        ISSN: 1741-427X            Impact factor:   2.629


In the article titled “Exploring the Pharmacological Mechanism of Liuwei Dihuang Decoction for Diabetic Retinopathy: A Systematic Biological Strategy-Based Research” [1], the order of affiliations has been corrected as above. The authors have also requested the following correction to the disclosure statement. Disclosure Mengxia Yuan, Shibin Lin, Qi He, and Zhiyong Long are to be considered the co-first authors. Shibin Lin is the first corresponding author because he supervised the study, and Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong is the first corresponding address.
  1 in total

1.  Exploring the Pharmacological Mechanism of Liuwei Dihuang Decoction for Diabetic Retinopathy: A Systematic Biological Strategy-Based Research.

Authors:  Mengxia Yuan; Qi He; Zhiyong Long; Xiaofei Zhu; Wang Xiang; Yonghe Wu; Shibin Lin
Journal:  Evid Based Complement Alternat Med       Date:  2021-08-02       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.